CA2556841C - Systeme et procede de reperage, d'analyse et de rapport de donnees medicales pour un systeme de soins de sante - Google Patents

Systeme et procede de reperage, d'analyse et de rapport de donnees medicales pour un systeme de soins de sante Download PDF

Info

Publication number: CA2556841C
Authority: CA; Canada
Prior art keywords: infusion; medical device; computer; order; medication
Prior art date: 2004-04-12
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA2556841A

Other languages

English (en)

Other versions

CA2556841A1 (fr

Inventor

Bryan Bello

Debra Bello

Barbara G. Browne

Tuan Bui

Manuel De Joya

Michele Kland

James P. Martucci

Janet Mullan

Ron Patry

Pauline Wong

Julianne Brushey

Alex Dolgovykh

Spencer Pye

Alex Reidiboim

Karen Ward

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Baxter International Inc

Original Assignee

Baxter International Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-04-12

Filing date

2005-03-29

Publication date

2015-01-06

2004-04-12 Priority claimed from US10/822,559 external-priority patent/US20050055242A1/en

2005-03-29 Application filed by Baxter International Inc filed Critical Baxter International Inc

2005-10-27 Publication of CA2556841A1 publication Critical patent/CA2556841A1/fr

2015-01-06 Application granted granted Critical

2015-01-06 Publication of CA2556841C publication Critical patent/CA2556841C/fr

2025-03-29 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 230
238000004458 analytical method Methods 0.000 title description 7
238000001802 infusion Methods 0.000 claims abstract description 1144
239000003814 drug Substances 0.000 claims abstract description 679
229940079593 drug Drugs 0.000 claims abstract description 677
230000006854 communication Effects 0.000 claims abstract description 198
238000004891 communication Methods 0.000 claims abstract description 196
238000012384 transportation and delivery Methods 0.000 claims abstract description 41
239000012530 fluid Substances 0.000 claims description 25
230000000977 initiatory effect Effects 0.000 claims description 25
230000005540 biological transmission Effects 0.000 claims description 9
238000005086 pumping Methods 0.000 claims description 6
238000012544 monitoring process Methods 0.000 abstract description 31
238000005516 engineering process Methods 0.000 abstract description 16
230000008569 process Effects 0.000 description 162
230000009471 action Effects 0.000 description 98
238000012986 modification Methods 0.000 description 63
230000004048 modification Effects 0.000 description 63
230000004044 response Effects 0.000 description 63
230000008859 change Effects 0.000 description 59
230000006870 function Effects 0.000 description 52
239000000243 solution Substances 0.000 description 48
238000007726 management method Methods 0.000 description 41
238000002483 medication Methods 0.000 description 36
238000002360 preparation method Methods 0.000 description 36
239000004615 ingredient Substances 0.000 description 35
238000012545 processing Methods 0.000 description 29
238000012795 verification Methods 0.000 description 28
238000013475 authorization Methods 0.000 description 25
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 24
238000012546 transfer Methods 0.000 description 22
230000000007 visual effect Effects 0.000 description 21
238000010586 diagram Methods 0.000 description 20
239000000654 additive Substances 0.000 description 17
238000013515 script Methods 0.000 description 17
239000003085 diluting agent Substances 0.000 description 15
238000002560 therapeutic procedure Methods 0.000 description 14
230000000875 corresponding effect Effects 0.000 description 13
238000004364 calculation method Methods 0.000 description 12
229960003638 dopamine Drugs 0.000 description 12
238000010200 validation analysis Methods 0.000 description 12
238000004448 titration Methods 0.000 description 11
235000021476 total parenteral nutrition Nutrition 0.000 description 11
238000013519 translation Methods 0.000 description 11
230000000474 nursing effect Effects 0.000 description 10
238000007639 printing Methods 0.000 description 10
230000000996 additive effect Effects 0.000 description 9
238000011049 filling Methods 0.000 description 9
206010020751 Hypersensitivity Diseases 0.000 description 8
238000001994 activation Methods 0.000 description 8
230000007815 allergy Effects 0.000 description 8
238000004590 computer program Methods 0.000 description 8
230000000004 hemodynamic effect Effects 0.000 description 8
BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 8
230000036961 partial effect Effects 0.000 description 8
238000012163 sequencing technique Methods 0.000 description 8
230000004913 activation Effects 0.000 description 7
238000005259 measurement Methods 0.000 description 7
230000003287 optical effect Effects 0.000 description 7
238000003825 pressing Methods 0.000 description 7
230000008901 benefit Effects 0.000 description 6
238000006243 chemical reaction Methods 0.000 description 6
238000004883 computer application Methods 0.000 description 6
238000013523 data management Methods 0.000 description 6
230000036541 health Effects 0.000 description 6
238000002347 injection Methods 0.000 description 6
239000007924 injection Substances 0.000 description 6
238000001990 intravenous administration Methods 0.000 description 6
229960004715 morphine sulfate Drugs 0.000 description 6
GRVOTVYEFDAHCL-RTSZDRIGSA-N morphine sulfate pentahydrate Chemical compound O.O.O.O.O.OS(O)(=O)=O.O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O.O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O GRVOTVYEFDAHCL-RTSZDRIGSA-N 0.000 description 6
239000000344 soap Substances 0.000 description 6
238000003860 storage Methods 0.000 description 6
230000001960 triggered effect Effects 0.000 description 6
230000010354 integration Effects 0.000 description 5
238000002372 labelling Methods 0.000 description 5
230000000737 periodic effect Effects 0.000 description 5
230000001360 synchronised effect Effects 0.000 description 5
208000036647 Medication errors Diseases 0.000 description 4
238000013459 approach Methods 0.000 description 4
230000006793 arrhythmia Effects 0.000 description 4
206010003119 arrhythmia Diseases 0.000 description 4
239000008280 blood Substances 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
238000013507 mapping Methods 0.000 description 4
229960005181 morphine Drugs 0.000 description 4
239000004065 semiconductor Substances 0.000 description 4
230000002596 correlated effect Effects 0.000 description 3
238000013500 data storage Methods 0.000 description 3
201000010099 disease Diseases 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
230000003993 interaction Effects 0.000 description 3
238000012423 maintenance Methods 0.000 description 3
238000012806 monitoring device Methods 0.000 description 3
230000003533 narcotic effect Effects 0.000 description 3
238000004806 packaging method and process Methods 0.000 description 3
239000004033 plastic Substances 0.000 description 3
229920001690 polydopamine Polymers 0.000 description 3
238000000926 separation method Methods 0.000 description 3
229910052710 silicon Inorganic materials 0.000 description 3
239000010703 silicon Substances 0.000 description 3
239000000126 substance Substances 0.000 description 3
238000012360 testing method Methods 0.000 description 3
206010013710 Drug interaction Diseases 0.000 description 2
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
241000931888 Pyxis Species 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
230000007175 bidirectional communication Effects 0.000 description 2
230000002457 bidirectional effect Effects 0.000 description 2
238000004422 calculation algorithm Methods 0.000 description 2
230000001413 cellular effect Effects 0.000 description 2
238000002512 chemotherapy Methods 0.000 description 2
230000001276 controlling effect Effects 0.000 description 2
235000014510 cooky Nutrition 0.000 description 2
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
230000000694 effects Effects 0.000 description 2
239000000835 fiber Substances 0.000 description 2
238000009093 first-line therapy Methods 0.000 description 2
235000013305 food Nutrition 0.000 description 2
230000030279 gene silencing Effects 0.000 description 2
229960002897 heparin Drugs 0.000 description 2
229920000669 heparin Polymers 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
COCAUCFPFHUGAA-MGNBDDOMSA-N n-[3-[(1s,7s)-5-amino-4-thia-6-azabicyclo[5.1.0]oct-5-en-7-yl]-4-fluorophenyl]-5-chloropyridine-2-carboxamide Chemical compound C=1C=C(F)C([C@@]23N=C(SCC[C@@H]2C3)N)=CC=1NC(=O)C1=CC=C(Cl)C=N1 COCAUCFPFHUGAA-MGNBDDOMSA-N 0.000 description 2
230000007170 pathology Effects 0.000 description 2
230000002093 peripheral effect Effects 0.000 description 2
230000000644 propagated effect Effects 0.000 description 2
230000010076 replication Effects 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
238000010079 rubber tapping Methods 0.000 description 2
238000012216 screening Methods 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
238000012876 topography Methods 0.000 description 2
210000003462 vein Anatomy 0.000 description 2
229940088594 vitamin Drugs 0.000 description 2
229930003231 vitamin Natural products 0.000 description 2
235000013343 vitamin Nutrition 0.000 description 2
239000011782 vitamin Substances 0.000 description 2
150000003722 vitamin derivatives Chemical class 0.000 description 2
FGRBYDKOBBBPOI-UHFFFAOYSA-N 10,10-dioxo-2-[4-(N-phenylanilino)phenyl]thioxanthen-9-one Chemical compound O=C1c2ccccc2S(=O)(=O)c2ccc(cc12)-c1ccc(cc1)N(c1ccccc1)c1ccccc1 FGRBYDKOBBBPOI-UHFFFAOYSA-N 0.000 description 1
HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
206010067484 Adverse reaction Diseases 0.000 description 1
206010001597 Alcohol interaction Diseases 0.000 description 1
241000144080 Alestes Species 0.000 description 1
101100451801 Arabidopsis thaliana HTT1 gene Proteins 0.000 description 1
206010013700 Drug hypersensitivity Diseases 0.000 description 1
206010016948 Food interaction Diseases 0.000 description 1
244000287680 Garcinia dulcis Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
208000005647 Mumps Diseases 0.000 description 1
208000005107 Premature Birth Diseases 0.000 description 1
208000032005 Spinocerebellar ataxia with axonal neuropathy type 2 Diseases 0.000 description 1
206010047700 Vomiting Diseases 0.000 description 1
230000005856 abnormality Effects 0.000 description 1
230000001133 acceleration Effects 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000006838 adverse reaction Effects 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000454 anti-cipatory effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
208000033361 autosomal recessive with axonal neuropathy 2 spinocerebellar ataxia Diseases 0.000 description 1
229940072293 axid Drugs 0.000 description 1
230000006399 behavior Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
XMQFTWRPUQYINF-UHFFFAOYSA-N bensulfuron-methyl Chemical compound COC(=O)C1=CC=CC=C1CS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 XMQFTWRPUQYINF-UHFFFAOYSA-N 0.000 description 1
FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
230000037396 body weight Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 1
239000003086 colorant Substances 0.000 description 1
238000004040 coloring Methods 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
229940109239 creatinine Drugs 0.000 description 1
238000013144 data compression Methods 0.000 description 1
230000034994 death Effects 0.000 description 1
230000000881 depressing effect Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
238000001647 drug administration Methods 0.000 description 1
238000012377 drug delivery Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
238000005429 filling process Methods 0.000 description 1
238000001914 filtration Methods 0.000 description 1
210000003811 finger Anatomy 0.000 description 1
239000011521 glass Substances 0.000 description 1
239000008103 glucose Substances 0.000 description 1
230000008676 import Effects 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
238000002642 intravenous therapy Methods 0.000 description 1
230000033001 locomotion Effects 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
208000010805 mumps infectious disease Diseases 0.000 description 1
239000004081 narcotic agent Substances 0.000 description 1
230000003589 nefrotoxic effect Effects 0.000 description 1
231100000381 nephrotoxic Toxicity 0.000 description 1
SGXXNSQHWDMGGP-IZZDOVSWSA-N nizatidine Chemical compound [O-][N+](=O)\C=C(/NC)NCCSCC1=CSC(CN(C)C)=N1 SGXXNSQHWDMGGP-IZZDOVSWSA-N 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
239000013307 optical fiber Substances 0.000 description 1
229940126701 oral medication Drugs 0.000 description 1
230000002572 peristaltic effect Effects 0.000 description 1
238000010926 purge Methods 0.000 description 1
230000001172 regenerating effect Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
210000001525 retina Anatomy 0.000 description 1
238000009420 retrofitting Methods 0.000 description 1
238000012552 review Methods 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
230000033772 system development Effects 0.000 description 1
210000003813 thumb Anatomy 0.000 description 1
238000013024 troubleshooting Methods 0.000 description 1
230000008673 vomiting Effects 0.000 description 1
235000012431 wafers Nutrition 0.000 description 1
239000002699 waste material Substances 0.000 description 1

Classifications

- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
General Health & Medical Sciences (AREA)
Medical Informatics (AREA)
Primary Health Care (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Business, Economics & Management (AREA)
General Business, Economics & Management (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
Measuring And Recording Apparatus For Diagnosis (AREA)

CA2556841A 2004-04-12 2005-03-29 Systeme et procede de reperage, d'analyse et de rapport de donnees medicales pour un systeme de soins de sante Expired - Fee Related CA2556841C (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US10/822,559		2004-04-12
US10/822,559 US20050055242A1 (en)	2002-04-30	2004-04-12	System and method for medical data tracking, analysis and reporting for healthcare system
PCT/US2005/010486 WO2005101279A2 (fr)	2004-04-12	2005-03-29	Systeme et procede de reperage, d'analyse et de rapport de donnees medicales pour un systeme de soins de sante

Publications (2)

Publication Number	Publication Date
CA2556841A1 CA2556841A1 (fr)	2005-10-27
CA2556841C true CA2556841C (fr)	2015-01-06

Family

ID=34980371

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2556841A Expired - Fee Related CA2556841C (fr)	2004-04-12	2005-03-29	Systeme et procede de reperage, d'analyse et de rapport de donnees medicales pour un systeme de soins de sante

Country Status (5)

Country	Link
EP (1)	EP1763810A2 (fr)
AU (2)	AU2005233945B2 (fr)
CA (1)	CA2556841C (fr)
NZ (1)	NZ550096A (fr)
WO (1)	WO2005101279A2 (fr)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8034026B2 (en)	2001-05-18	2011-10-11	Deka Products Limited Partnership	Infusion pump assembly
EP1815879A3 (fr)	2001-05-18	2007-11-14	Deka Products Limited Partnership	Perfuseur pour pompe à liquide
US8666760B2 (en)	2005-12-30	2014-03-04	Carefusion 303, Inc.	Medication order processing and reconciliation
US11478623B2 (en)	2006-02-09	2022-10-25	Deka Products Limited Partnership	Infusion pump assembly
US12370305B2 (en)	2006-02-09	2025-07-29	Deka Products Limited Partnership	Patch-sized fluid delivery systems and methods
US10010669B2 (en)	2006-02-09	2018-07-03	Deka Products Limited Partnership	Systems and methods for fluid delivery
US11497846B2 (en)	2006-02-09	2022-11-15	Deka Products Limited Partnership	Patch-sized fluid delivery systems and methods
US11364335B2 (en)	2006-02-09	2022-06-21	Deka Products Limited Partnership	Apparatus, system and method for fluid delivery
US11027058B2 (en)	2006-02-09	2021-06-08	Deka Products Limited Partnership	Infusion pump assembly
US12070574B2 (en)	2006-02-09	2024-08-27	Deka Products Limited Partnership	Apparatus, systems and methods for an infusion pump assembly
US12151080B2 (en)	2006-02-09	2024-11-26	Deka Products Limited Partnership	Adhesive and peripheral systems and methods for medical devices
US12274857B2 (en)	2006-02-09	2025-04-15	Deka Products Limited Partnership	Method and system for shape-memory alloy wire control
EP3165247B1 (fr)	2006-02-09	2020-10-28	DEKA Products Limited Partnership	Systèmes de distribution de fluides de pompage et procédés utilisant un ensemble d'application de force
US8149131B2 (en)	2006-08-03	2012-04-03	Smiths Medical Asd, Inc.	Interface for medical infusion pump
US9543920B2 (en)	2006-10-24	2017-01-10	Kent E. Dicks	Methods for voice communication through personal emergency response system
US8126735B2 (en)	2006-10-24	2012-02-28	Medapps, Inc.	Systems and methods for remote patient monitoring and user interface
US8966235B2 (en)	2006-10-24	2015-02-24	Kent E. Dicks	System for remote provisioning of electronic devices by overlaying an initial image with an updated image
US8126732B2 (en)	2006-10-24	2012-02-28	Medapps, Inc.	Systems and methods for processing and transmittal of medical data through multiple interfaces
US8131566B2 (en)	2006-10-24	2012-03-06	Medapps, Inc.	System for facility management of medical data and patient interface
US8126734B2 (en)	2006-10-24	2012-02-28	Medapps, Inc.	Systems and methods for adapter-based communication with a medical device
WO2008051939A2 (fr) *	2006-10-24	2008-05-02	Medapps, Inc.	Systèmes et procédés pour un échange de données médicales
US8954719B2 (en)	2006-10-24	2015-02-10	Kent E. Dicks	Method for remote provisioning of electronic devices by overlaying an initial image with an updated image
US8126733B2 (en)	2006-10-24	2012-02-28	Medapps, Inc.	Systems and methods for medical data interchange using mobile computing devices
US8126729B2 (en)	2006-10-24	2012-02-28	Medapps, Inc.	Systems and methods for processing and transmittal of data from a plurality of medical devices
US8126730B2 (en)	2006-10-24	2012-02-28	Medapps, Inc.	Systems and methods for storage and forwarding of medical data
US8126728B2 (en)	2006-10-24	2012-02-28	Medapps, Inc.	Systems and methods for processing and transmittal of medical data through an intermediary device
EP2084633A2 (fr) *	2006-11-21	2009-08-05	Baxter International Inc.	Système et procédé destinés à la surveillance et/ou à la gestion à distance de thérapies d'infusion
NL1033901C2 (nl) *	2007-01-25	2008-07-28	Youssef Belmahi	Medicatiecontroleapparaat.
CA2677667A1 (fr)	2007-02-09	2008-08-14	Deka Products Limited Partnership	Ensemble d'insertion automatise
US9526830B2 (en)	2007-12-31	2016-12-27	Deka Products Limited Partnership	Wearable pump assembly
US9456955B2 (en)	2007-12-31	2016-10-04	Deka Products Limited Partnership	Apparatus, system and method for fluid delivery
CA2919786C (fr)	2007-12-31	2019-10-22	Deka Products Limited Partnership	Systeme de pompe a perfusion
US8881774B2 (en)	2007-12-31	2014-11-11	Deka Research & Development Corp.	Apparatus, system and method for fluid delivery
US8900188B2 (en)	2007-12-31	2014-12-02	Deka Products Limited Partnership	Split ring resonator antenna adapted for use in wirelessly controlled medical device
US10080704B2 (en)	2007-12-31	2018-09-25	Deka Products Limited Partnership	Apparatus, system and method for fluid delivery
US10188787B2 (en)	2007-12-31	2019-01-29	Deka Products Limited Partnership	Apparatus, system and method for fluid delivery
AU2010236090B2 (en) *	2008-04-01	2014-06-26	Icu Medical, Inc.	Software features for medical infusion pump
WO2009124134A2 (fr)	2008-04-01	2009-10-08	Smiths Medical Md, Inc.	Particularités logicielles pour pompe d’infusion médicale
US8057679B2 (en)	2008-07-09	2011-11-15	Baxter International Inc.	Dialysis system having trending and alert generation
US10089443B2 (en)	2012-05-15	2018-10-02	Baxter International Inc.	Home medical device systems and methods for therapy prescription and tracking, servicing and inventory
US8990924B2 (en)	2008-08-27	2015-03-24	Medtronic, Inc.	Multiple user accounts for managing stored information in an implantable medical device system
US8016789B2 (en)	2008-10-10	2011-09-13	Deka Products Limited Partnership	Pump assembly with a removable cover assembly
US8708376B2 (en)	2008-10-10	2014-04-29	Deka Products Limited Partnership	Medium connector
US12370327B2 (en)	2008-10-10	2025-07-29	Deka Products Limited Partnership	Infusion pump methods, systems and apparatus
US8066672B2 (en)	2008-10-10	2011-11-29	Deka Products Limited Partnership	Infusion pump assembly with a backup power supply
US9180245B2 (en)	2008-10-10	2015-11-10	Deka Products Limited Partnership	System and method for administering an infusible fluid
US8223028B2 (en)	2008-10-10	2012-07-17	Deka Products Limited Partnership	Occlusion detection system and method
US8262616B2 (en)	2008-10-10	2012-09-11	Deka Products Limited Partnership	Infusion pump assembly
US8267892B2 (en)	2008-10-10	2012-09-18	Deka Products Limited Partnership	Multi-language / multi-processor infusion pump assembly
US12186531B2 (en)	2008-10-10	2025-01-07	Deka Products Limited Partnership	Infusion pump assembly
WO2011008966A2 (fr)	2009-07-15	2011-01-20	Deka Products Limited Partnership	Appareil, systèmes et procédés pour un ensemble pompe à perfusion
US9077544B2 (en)	2009-09-15	2015-07-07	Welch Allyn, Inc.	Automatic provisioning of authentication credentials
CA3033439C (fr)	2010-01-22	2021-04-06	Deka Products Limited Partnership	Procede et systeme pour le controle d'un fil en acier allie a memoire de forme
US9930297B2 (en)	2010-04-30	2018-03-27	Becton, Dickinson And Company	System and method for acquiring images of medication preparations
EP2601605A1 (fr) *	2010-08-03	2013-06-12	Koninklijke Philips Electronics N.V.	Procédé d'affichage et de navigation pour événements cliniques
US11524151B2 (en)	2012-03-07	2022-12-13	Deka Products Limited Partnership	Apparatus, system and method for fluid delivery
US10650917B2 (en) *	2012-07-02	2020-05-12	Carefusion 303, Inc.	Patient-device association system
US20150356252A1 (en) *	2013-01-16	2015-12-10	Medaware Ltd.	Medical database and system
AU2014239597B2 (en)	2013-03-15	2018-03-22	Gambro Lundia Ab	Extracorporeal blood treatment apparatus with reservoir status lights
US20160058673A1 (en) *	2013-05-01	2016-03-03	Nathania Alexandra Francis	System and method for monitoring administration of nutrition
US9617020B2 (en)	2013-07-03	2017-04-11	Deka Products Limited Partnership	Apparatus, system and method for fluid delivery
US9507914B2 (en)	2013-07-17	2016-11-29	Merge Healthcare Incorporated	User-definable morphers for medical data and graphical user interface for the same
ITMI20131321A1 (it)	2013-08-02	2015-02-03	Dml Ablogics Ltd	Sistema telematico per la raccolta e l'analisi dei dati e dei risultati di saggi auto-diagnostici in una popolazione di utenti, corrispondente metodo, e apparecchiatura elettronica periferica di servizio e kit di auto-diagnostica per un uso in tale s
WO2016023151A1 (fr) *	2014-08-11	2016-02-18	深圳迈瑞生物医疗电子股份有限公司	Procédé et système de transmission de données d'appareil médical
JP6514771B2 (ja)	2014-09-29	2019-05-15	アベリー・デニソン・コーポレイションＡｖｅｒｙＤｅｎｎｉｓｏｎＣｏｒｐｏｒａｔｉｏｎ	タイヤ追跡ｒｆｉｄラベル
US11329683B1 (en)	2015-06-05	2022-05-10	Life365, Inc.	Device configured for functional diagnosis and updates
US10560135B1 (en)	2015-06-05	2020-02-11	Life365, Inc.	Health, wellness and activity monitor
US9974492B1 (en)	2015-06-05	2018-05-22	Life365, Inc.	Health monitoring and communications device
US10185513B1 (en)	2015-06-05	2019-01-22	Life365, Inc.	Device configured for dynamic software change
CN106254401B (zh) *	2015-06-08	2022-02-25	腾讯科技（深圳）有限公司	网络通信中的社交关系建立方法、终端设备、智能设备
US10388411B1 (en)	2015-09-02	2019-08-20	Life365, Inc.	Device configured for functional diagnosis and updates
EP3398096A2 (fr)	2015-12-31	2018-11-07	Koninklijke Philips N.V.	Commande à imagerie par résonance magnétique (irm)
US10964417B2 (en)	2016-12-21	2021-03-30	Baxter International Inc.	Medical fluid delivery system including a mobile platform for patient engagement and treatment compliance
US10589014B2 (en)	2016-12-21	2020-03-17	Baxter International Inc.	Medical fluid delivery system including remote machine updating and control
US20200211687A1 (en) *	2017-05-09	2020-07-02	Medipick Pty Ltd	Medical prescription management system and method
US20200097910A1 (en) *	2017-06-12	2020-03-26	Sensory Technologies Of Canada Inc.	A system for generating a record of community-based patient care
CN108492868A (zh) *	2018-03-06	2018-09-04	上海京颐科技股份有限公司	医疗移动终端及其功能模块控制方法、装置、存储介质
CA3098372A1 (fr)	2018-04-24	2019-10-31	Deka Products Limited Partnership	Appareil et systeme pour la distribution de fluide
CN112153334B (zh) *	2020-09-15	2023-02-21	公安部第三研究所	用于安全管理的智能视频盒子设备及相应的智能视频分析方法
WO2022144239A1 (fr)	2020-12-28	2022-07-07	Fresenius Vial Sas	Système pour fournir de multiples perfusions à un patient
CN112735567B (zh) *	2021-01-07	2024-02-02	南京巨鲨显示科技有限公司	一种具有自动归档功能的医用录播系统及其录播方法
CN112906051B (zh) *	2021-03-02	2022-09-20	上海蓝色帛缔智能工程有限公司	智慧医疗数据处理方法、系统及数据中心
CN114886417B (zh) *	2022-05-10	2023-09-22	南京布尔特医疗技术发展有限公司	一种智能化安全护理监控系统及方法
US20240366866A1 (en) *	2023-05-03	2024-11-07	Embecta Corp.	Systems and Methods for Monitoring Operations of an Infusion Delivery Device Using a Pressure Sensor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6577899B2 (en) *	2000-01-21	2003-06-10	Medtronic Minimed, Inc.	Microprocessor controlled ambulatory medical apparatus with hand held communication device
US9135393B1 (en) *	2000-08-02	2015-09-15	Smiths Medical Asd, Inc.	Processing program data for medical pumps
US7154397B2 (en) *	2001-08-03	2006-12-26	Hill Rom Services, Inc.	Patient point-of-care computer system

2005
- 2005-03-29 CA CA2556841A patent/CA2556841C/fr not_active Expired - Fee Related
- 2005-03-29 AU AU2005233945A patent/AU2005233945B2/en not_active Ceased
- 2005-03-29 EP EP05734940A patent/EP1763810A2/fr not_active Ceased
- 2005-03-29 NZ NZ550096A patent/NZ550096A/en not_active IP Right Cessation
- 2005-03-29 WO PCT/US2005/010486 patent/WO2005101279A2/fr active Application Filing
2011
- 2011-04-27 AU AU2011201894A patent/AU2011201894B2/en not_active Ceased

Also Published As

Publication number	Publication date
AU2005233945A1 (en)	2005-10-27
AU2011201894A1 (en)	2011-05-19
AU2005233945B2 (en)	2011-01-27
CA2556841A1 (fr)	2005-10-27
WO2005101279A3 (fr)	2006-08-10
AU2011201894B2 (en)	2012-06-21
EP1763810A2 (fr)	2007-03-21
NZ550096A (en)	2008-07-31
WO2005101279A2 (fr)	2005-10-27

Publication	Publication Date	Title
CA2556841C (fr)	2015-01-06	Systeme et procede de reperage, d'analyse et de rapport de donnees medicales pour un systeme de soins de sante
AU2004209134B2 (en)	2009-11-05	Method and system for medical device connectivity
CA2514294C (fr)	2014-08-19	Systeme et procede de notification de communication de donnees medicales et de messagerie
AU2004209120B2 (en)	2008-05-29	System and method for verifying medical device operational parameters
CA2514571C (fr)	2019-01-15	Systeme et procede de communication de donnees medicales sans fil
US20050055242A1 (en)	2005-03-10	System and method for medical data tracking, analysis and reporting for healthcare system
US20040172301A1 (en)	2004-09-02	Remote multi-purpose user interface for a healthcare system
US20050055244A1 (en)	2005-03-10	Wireless medical communication system and method
US20040172300A1 (en)	2004-09-02	Method and system for integrating data flows
US20050065817A1 (en)	2005-03-24	Separation of validated information and functions in a healthcare system
WO2004070562A2 (fr)	2004-08-19	Systeme et procede de notification et de transmission de donnees medicales
WO2004070995A2 (fr)	2004-08-19	Systeme et procede d'authentification de dispositif medical

Legal Events

Date	Code	Title	Description
2010-03-19	EEER	Examination request
2018-05-10	MKLA	Lapsed	Effective date: 20180329